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Predicting mortality has been a corner piece of critical
care research and practise dating back to the first
descriptions of the Acute Physiology and Chronic Health
Evaluation score in 1981 [1]. With an increasing burden
of non-communicable disease in modern society, pre-
existing functional status seems to an important
contributor to outcome prediction. Poor physical func-
tion is an important predictor of mortality in ambulant
diseases. The construct of frailty [2], translated from
older patient care into critical care, has provided a useful
language to discuss pre-morbid functional status.
Whilst frailty can be established from history taking or
hospital coding, both of these methods have clinical and
research methodological disadvantages. Wilhelmus et al.
[3] now offer an alternative approach in a retrospective
analysis of computerized tomography scans. Muscle
quality as defined by Hounsfield units at the level of L3
was investigated in 491 patients, with a threshold set to
define intramuscular adipose tissue and visceral adipose
tissue. Higher skeletal muscle density (i.e. better quality)
was associated with lower 6-month mortality and
shorter hospital length of stay after correction for
muscle mass and severity of illness.
Skeletal muscle quality is recognized as a marker of
function in healthy individuals [4] and critically ill patients
[5]. Alterations are seen with aging [4], immobilization
[6], chronic disease states [7] and critical illness [8]. These
conditions demonstrate qualitative changes in muscle
structure as a result of increasing collagen and lipid
deposition [6]. Intramyocellular lipid accumulation is
additionally a hallmark of metabolic diseases, and
may exacerbate tissue metabolic derangements in the
critically ill.
A limitation of these data is the inability to relate
either chronic disease states and poor muscle quality, or
muscle quality and functional outcomes. However,
decreased skeletal muscle density as an independent pre-
dictor of mortality raises the possibility of its use in
multi-dimensional scoring systems such as the NUTRIC
score [9] or as an alternative marker of chronic poor
physiological reserve in the APACHE system.
A number of key roles for early trajectory assessments
exist. First, novel early outcome predictors are needed to
guide patient and family expectations and decision-
making. These need to not only predict risk of death,
but also disability, so a patient’s wishes may be honoured
and a realistic appraisal of functional outcomes can be
made. It is vital we improve upon our ability to inform
patients and families early in critical illness on the likeli-
hood of significant morbidity. It is possible that admis-
sion skeletal muscle quality and quantity may be key to
this discussion in the future. Ongoing testing via lean
body mass ultrasound [8] and other modalities [10] may
also be vital to continued discussions of prognosis.
Second, these tests of muscle quality should assist in
guiding therapy. A recent post-ICU recovery consensus
conference indicated that a major gap exists in under-
standing how to effectively and efficiently screen patients
for specific post-ICU impairments to determine the need
for further diagnostic work-up and treatment [11].
Thirdly, the current controversy around personalizing
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nutrition delivery in the ICU to optimize outcome [12]
has begun to be addressed by early studies validating the
role of the aforementioned NUTRIC score in nutrition
risk prediction [9]. High malnutrition risk patients may
benefit to a greater degree than those with lower risk. A
key addition to this prediction of nutrition risk may be
muscle quantity and quality at ICU admission. The abil-
ity of the muscle to utilize substrate such as lipid and
overall glycogen content [10] may be key in delivering
personalized nutrition to improve outcomes. Patients with
low muscle quality and quantity may have greater and
different specific nutritional requirements. Conversely,
increased muscle myosteatosis as defined by decreased
skeletal muscle density or increased intermuscular adipose
tissue may indicate impaired muscle substrate utilization
as implied by Wilhelmus et al. [3]. This may indicate that
nutrition delivery needs to account for impaired substrate
(lipid) utilization and/or measures need to be taken to im-
prove muscle lipid uptake/utilization (e.g. carnitine [13]).
Finally, exercise and reduction of immobility are essential
to reduce impaired muscle substrate metabolism and thus
improve poor muscle quality.
These assessments may be a key innovation prior to
major surgery or cancer therapy. Patients with poor
skeletal muscle quality could then be enrolled in preha-
bilitative exercise/nutrition programmes to improve
skeletal muscle quality and quantity [14]. Clinical trials
systematically evaluating muscle quality and quantity
measures via CT scan and ultrasound could then be per-
formed to assess interventions and target ideal methods
to optimize patients. Further, in the ICU, these tech-
niques need further study to determine the muscle-level
effects of individual nutrition (e.g. protein delivery,
anabolic agents [10]) and specific ICU-rehabilitation in-
terventions (e.g. in-bed ergometry, functional electrical
stimulation [15]). Current functional testing (i.e. Medical
Research Council sum score, hand-grip strength, walk
testing) is both volitional and not muscle specific, and
has significant implementation, interpretation and com-
pliance challenges. Thus, the role of muscle quality and
quantity measurement described here deserves add-
itional study and validation to add an additional “dimen-
sion” to our prediction of outcome and personalization
of care in the ICU.
Abbreviations
APACHE: Acute Physiology and Chronic Health Evaluation; CT: Computerized
Tomography; ICU: Intensive care unit; NUTRIC: Nutrition Risk in Critically Ill
Acknowledgements
None.
Funding
Not applicable.
Availability of data and materials
Not applicable.
Authors’ contributions
Both authors contributed equally. Both authors read and approved the final
manuscript.
Authors’ information
See Authors’ contributions.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Institute of Sports and Exercise Health, University College London Hospitals,
1st Floor, 170 Tottenham Court Road, London W1T 7HA, UK. 2Division of
Critical Care, University College London Hospitals, London, UK. 3Department
of Anesthesiology, Duke University of Medicine, Durham, USA. 4Duke Clinical
Research Institute, Duke University of Medicine, Durham, USA.
References
1. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE—acute physiology
and chronic health evaluation: a physiologically based classification system.
Crit Care Med. 1981;9(8):591–7.
2. Bagshaw SM, McDermid RC. The role of frailty in outcomes from critical
illness. Curr Opin Crit Care. 2013;19(5):496–503.
3. Wilhelmus GPM, Looijaard IMD, Stapel SN, Girbes ARJ, Twisk JWR,
Oudemans-van Straaten HM, Weijs PJM. Skeletal muscle quality as assessed
by CT-derived skeletal muscle density is associated with 6-month mortality
in mechanically ventilated critically ill patients. Crit Care. 2016.
4. Watanabe Y, Yamada Y, Fukumoto Y, et al. Echo intensity obtained from
ultrasonography images reflecting muscle strength in elderly men. Clin
Interv Aging. 2013;8:993–8.
5. Parry SM, El-Ansary D, Cartwright MS, et al. Ultrasonography in the intensive
care setting can be used to detect changes in the quality and quantity of
muscle and is related to muscle strength and function. J Crit Care. 2015;
30(5):1151. e9-51 e14.
6. Parry SM, Puthucheary ZA. The impact of extended bed rest on the musculoskeletal
system in the critical care environment. Extrem Physiol Med. 2015;4:16.
7. McNelly AS, Rawal J, Shrikrishna D, et al. An exploratory study of long-term
outcome measures in critical illness survivors: construct validity of physical
activity, frailty, and health-related quality of life measures. Crit Care Med.
2016;44(6):e362–369.
8. Puthucheary ZA, Phadke R, Rawal J, et al. Qualitative ultrasound in acute
critical illness muscle wasting. Crit Care Med. 2015;43(8):1603–11.
9. Rahman A, Hasan RM, Agarwala R, et al. Identifying critically-ill patients who
will benefit most from nutritional therapy: further validation of the “modified
NUTRIC” nutritional risk assessment tool. Clin Nutr. 2016;35(1):158–62.
10. Wischmeyer PE, San-Millan I. Winning the war against ICU-acquired
weakness: new innovations in nutrition and exercise physiology. Crit Care.
2015;19 Suppl 3:S6.
11. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes
after discharge from intensive care unit: report from a stakeholders’
conference. Crit Care Med. 2012;40(2):502–9.
12. Wischmeyer PE. Are we creating survivors … or victims in critical care?
Delivering targeted nutrition to improve outcomes. Curr Opin Crit Care.
2016;22(4):279–84.
13. Bonafe L, Berger MM, Que YA, et al. Carnitine deficiency in chronic critical
illness. Curr Opin Clin Nutr Metab Care. 2014;17(2):200–9.
14. Carli F, Minnella EM. Preoperative functional assessment and optimization in
surgical patient. Changing the paradigm. Minerva Anestesiol. 2016. [Epub
ahead of print].
15. Parry SM, Berney S, Warrillow S, et al. Functional electrical stimulation with
cycling in the critically ill: a pilot case-matched control study. J Crit Care.
2014;29(4):695. e1–7.
Puthucheary and Wischmeyer Critical Care  (2017) 21:20 Page 2 of 2
